Next Pharmaceuticals Discloses Results of Nexrutine(R) Clinical Study
Results of a clinical study on Nexrutine, conducted at The LaValle Metabolic Institute in Cincinnati, Ohio, indicated that of 401 participants 369 (92 per cent) reported the product provided pain relief and 373 (93 per cent) reported improvement in their overall condition.
Read the full article…

Frutarom's Neuravena improves stress-coping abilities and cognitive function
Neuravena (EFLA955), Frutarom's wild green-oat extract, has been shown to enhance stress-coping abilities as well as learning performance. The phytonutrients present in the extract are thought to affect the activity of cerebral enzymes closely related to mental health and cognitive function. The conclusions drawn from previous in-vitro studies have now been confirmed by two in-vivo investigations.
Read the full article…

InterHealth's Uc-II for arthritis
InterHealth Nutraceuticals' patented ingredient, UC-II, shows value relative to both osteoarthritis and rheumatoid arthritis. Evidence on UC-II, the only source of undenatured (native) type II collagen available as a dietary ingredient, was presented at the SupplySide West conference in Las Vegas.
Read the full article…

Jarrow's flax essential for glycaemic control
In a randomised, controlled crossover study, published in online peer-reviewed journal PLoS (PloS.org), the effects of 360mg/day SDG flax lignans were investigated in 68 Type 2 diabetic patients. The study used Jarrow Formulas Flax Essence as the source material.
Read the full article…